Robotic-assisted Gait Training Combined With Transcranial Direct Current Stimulation to Maximize Gait Recovery After Stroke

December 18, 2016 updated by: Byung-Mo Oh, Seoul National University Hospital

Robotic-assisted Gait Training Combined With Transcranial Direct Current Stimulation to Maximize Gait Recovery After Stroke: A Double-blind, Randomized, Controlled Trial

  1. Study objective To evaluate the effect of robotic-assisted gait training combined with transcranial direct current stimulation (tDCS) as compared to that of robotic-assisted gait training on gait function of chronic stroke patients
  2. Subjects chronic stroke patients with gait impairment
  3. Methods

    • Group 1: Robotic-assisted gait training with anodal tDCS (45 min)
    • Group 2: Robotic-assisted gait training with sham tDCS (45 min)
    • Duration of treatment: 2 weeks, 5 times a week
    • Evaluation: Baseline, 1 day after the treatment, 4 weeks after the treatment

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

21

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Seoul, Korea, Republic of, 110-744
        • Seoul National University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Stroke patients who diagnosed by computed tomography or magnetic resonance imaging
  • Hemiplegic patients due to unilateral lesion
  • Patients in chronic stage after 6 months from stroke onset
  • Patients with gait impairment (FAC <= 4)
  • Adult (Age >= 18)

Exclusion Criteria:

  • Unstable vital sign
  • History of seizure or cranial operation
  • unable to walk before stroke
  • bilateral hemispheric lesions
  • metalic implant (cardiac pacemaker, artificial cochlear, etc.)
  • severe cognitive deficit, MMSE < 10
  • severe aphasic patient who cannot communicate at all

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Robot + anodal tDCS
Robotic-assisted gait training for 45 min after anodal tDCS on impaired motor cortex for 20 min
tDCS will be applied on the primary motor cortex of the lower limb in the impared hemisphere before robotic-assisted gait training. Anodal tDCS will be applied with an intensity of 2mA for 20 min. Sham tDCS will be applied with an intensity of 2mA just for 1 min, after which the current will be slowly tapered down to 0 over a several seconds.
Other Names:
  • DC-Stimulator Plus (NeuroConn GmbH, Ilmenaus, Germany)
Robotic-assisted gait training with an exoskeletal type robot which simulates normal walking on a treadmill for patients with gait impairments
Other Names:
  • Walkbot_S (P&S Mechanics Co. Ltd., Seoul, Korea)
Sham Comparator: Robot + sham tDCS
Robotic-assisted gait training for 45 min after sham tDCS on impaired motor cortex for 20 min
tDCS will be applied on the primary motor cortex of the lower limb in the impared hemisphere before robotic-assisted gait training. Anodal tDCS will be applied with an intensity of 2mA for 20 min. Sham tDCS will be applied with an intensity of 2mA just for 1 min, after which the current will be slowly tapered down to 0 over a several seconds.
Other Names:
  • DC-Stimulator Plus (NeuroConn GmbH, Ilmenaus, Germany)
Robotic-assisted gait training with an exoskeletal type robot which simulates normal walking on a treadmill for patients with gait impairments
Other Names:
  • Walkbot_S (P&S Mechanics Co. Ltd., Seoul, Korea)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional Ambulatory Category (FAC)
Time Frame: Baseline
Assesses functional ambulation in patients undergoing physical therapy
Baseline
Functional Ambulatory Category (FAC)
Time Frame: 1 day after treatment
Assesses functional ambulation in patients undergoing physical therapy
1 day after treatment
Functional Ambulatory Category (FAC)
Time Frame: 4 weeks after treatment
Assesses functional ambulation in patients undergoing physical therapy
4 weeks after treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
10-meter walk test
Time Frame: Baseline
Time for walking 10 meters
Baseline
10-meter walk test
Time Frame: 1 day after treatment
Time for walking 10 meters
1 day after treatment
10-meter walk test
Time Frame: 4 weeks after treatment
Time for walking 10 meters
4 weeks after treatment
6-min walk test
Time Frame: Baseline
Walking distance for 6 min
Baseline
6-min walk test
Time Frame: 1 day after treatment
Walking distance for 6 min
1 day after treatment
6-min walk test
Time Frame: 4 weeks after treatment
Walking distance for 6 min
4 weeks after treatment
Modified Rankin's Scale
Time Frame: Baseline
Baseline
Modified Rankin's Scale
Time Frame: 1 day after treatment
1 day after treatment
Modified Rankin's Scale
Time Frame: 4 weeks after treatment
4 weeks after treatment
Fugl-Meyer assessment scale for lower extremity
Time Frame: Baseline
Assess the function of lower extremity in stroke patients
Baseline
Fugl-Meyer assessment scale for lower extremity
Time Frame: 1 day after treatment
Assess the function of lower extremity in stroke patients
1 day after treatment
Fugl-Meyer assessment scale for lower extremity
Time Frame: 4 weeks after treatment
Assess the function of lower extremity in stroke patients
4 weeks after treatment
Motor evoked potential
Time Frame: Baseline
Assess motor pathway from brain cortex to the muscle by transcranial magnetic stimulation
Baseline
Motor evoked potential
Time Frame: 1 day after treatment
Assess motor pathway from brain cortex to the muscle by transcranial magnetic stimulation
1 day after treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Byung-Mo Oh, MD, PhD, Seoul National University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2013

Primary Completion (Actual)

December 1, 2016

Study Registration Dates

First Submitted

September 15, 2013

First Submitted That Met QC Criteria

September 17, 2013

First Posted (Estimate)

September 18, 2013

Study Record Updates

Last Update Posted (Estimate)

December 20, 2016

Last Update Submitted That Met QC Criteria

December 18, 2016

Last Verified

December 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on tDCS

Subscribe